Market closed · Next open: Monday 9:30 AM ET
Last update: Oct 30, 2026, 6:17 PM ET
McKesson Corporation
$994.58▲ 1.40% today
Market Closed

Why McKesson Corporation (MCK) stock moved

Updated Nov 1, 2026

McKesson Corporation (MCK) shares rose 1.4% to $994.58 as of November 1, 2026, a modest gain from the prior close of $980.88. BestStocks flagged the session as a major change for MCK. The move is tied to company news. Below, we break down what changed for MCK, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Company News

McKesson reports Q2 earnings for quarter ended September 2026 with Wall Street monitoring top-line and bottom-line performance. Q2 results and key metrics reveal McKesson's operational efficiency and profitability trends amid healthcare distribution sector dynamics.

This summary describes the catalyst and move as first detected on Oct 30, 2026, 10:24 AM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
NewsWeak confidence
Rel. volume
0.8×
Below Avg
Vs peers
—
No comparable peers
Market cap
$116.0B
New York Stock Exchange
Analyst target
$983
-1.2% vs price
Price chart
Oct 1 – Oct 30
VVNNNNNNNNNF$897$965$1032Oct 1Oct 8Oct 16Oct 23Oct 30
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for McKesson Corporation investors

For McKesson Corporation investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 1.4% session move; Positive price momentum. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $983.13, implying -1.2% downside from $994.58. BestStocks rates the overall signal quality weak (39/100). With earnings roughly 3 days out, the next report is the most likely near-term test of the move.

MCK price reaction

MCK last traded at $994.58, up $13.70 (+1.40%) from the previous close of $980.88. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $898.82 and $1,030.12, and it currently sits about 73% of the way up that band.

Bullish and bearish analyst opinions on McKesson Corporation (MCK)

The consensus analyst price target on McKesson Corporation (MCK) is $983.13, 1.2% below the recent $994.58. Over the past 90 days analysts logged 0 upgrades, 9 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MCK line up.

The bullish case

  • The Street's most bullish target is $1,200.00 (+20.7%).
  • Positive 1.4% session move.
  • Positive price momentum.
  • McKesson Corporation (MCK) moved +5.65% from $796.35 to $841.31 on 2026-07-16, reaching a new 30-day high on modestly elevated volume (1.7x the 5-day average).

The bearish case

  • The consensus analyst price target of $983.13 sits 1.2% below the recent $994.58, so the average target sees limited room to run.
  • The most bearish analyst target is $845.00 (-15.0%).
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 1, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $983-1.2%
= 9 maintains
Mizuho maintained Neutral · 2026-10-20
SEC filings watch
8-K2026-10-06
Material event — review for impact
high
8-K2026-08-28
Material event — review for impact
high
10-Q2026-08-05
Quarterly financial results
medium
8-K2026-08-05
Material event — review for impact
high
Peer context
MCK+1.4%

Previous notable changes for MCK

News2026-10-28-0.7%
McKesson lacks key factors needed to beat upcoming earnings expectations.
News2026-10-27-2.6%
Zacks ratings identify McKesson as strong momentum stock based on Style Score analysis.
News2026-10-22-0.3%
MCK positioned to gain from AI-driven prescription automation and FDA rare-disease drug approval acceleration in 2027.
News2026-10-21-1.4%
MCK stock declined 1.42% to $1 per share in latest trading.
Upcoming catalysts & outlook
Next earnings
2026-11-04 (est.)
in 3 days
Thesis shift
Neutral / Mixed
bullish signal
Risk level
Low
from change events

Frequently asked questions about MCK

Why did McKesson Corporation (MCK) stock move?

MCK rose 1.4% to $994.58. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.

How much did MCK stock rise?

MCK gained 1.40% ($13.70) versus the prior close of $980.88, last trading at $994.58 on 0.8× average volume.

When is McKesson Corporation's next earnings date?

MCK's next earnings report is estimated for 2026-11-04 — about 3 days away.

What is the analyst price target for MCK?

The consensus analyst price target for MCK is $983.13, about 1.2% below the current $994.58. Over the past 90 days, analysts recorded 0 upgrades, 9 maintains, and 0 downgrades.

How BestStocks tracks MCK

This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for MCK, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 1, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.